FTD
Clinical trials for FTD explained in plain language.
Never miss a new study
Get alerted when new FTD trials appear
Sign up with your email to follow new studies for FTD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gene therapy trial hopes to halt rare dementia
Disease control Recruiting nowThis study tests a one-time gene therapy called AVB-101 for people with a specific genetic form of frontotemporal dementia (FTD-GRN). The therapy is injected directly into the brain to restore a missing protein and potentially slow or stop the disease. 18 adults aged 30-75 with e…
Matched conditions: FTD
Phase: PHASE1, PHASE2 • Sponsor: AviadoBio Ltd • Aim: Disease control
Last updated May 20, 2026 11:55 UTC
-
Can magnetic pulses ease frontotemporal dementia?
Symptom relief Recruiting nowThis study tests if a non-invasive brain stimulation technique called rTMS is safe and helpful for people with frontotemporal dementia (FTLD) or those at risk. About 120 participants will receive either real or placebo stimulation for 2 weeks, then everyone gets real stimulation.…
Matched conditions: FTD
Phase: NA • Sponsor: Università degli Studi di Brescia • Aim: Symptom relief
Last updated May 26, 2026 05:23 UTC
-
Scientists hunt for hidden signs of ALS and FTD in body fluids
Knowledge-focused Recruiting nowThis study aims to find biological markers (biomarkers) in body fluids and tissues that can help doctors diagnose ALS and FTD more accurately and earlier. Researchers will analyze samples from 230 people, including those with ALS, FTD, and other conditions, using advanced techniq…
Matched conditions: FTD
Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated May 26, 2026 05:05 UTC
-
Scientists hunt for hidden clues in brain disease genes
Knowledge-focused Recruiting nowThis study aims to find new markers in our DNA, proteins, and metabolism that could help diagnose and track brain diseases like Alzheimer's, Parkinson's, and ALS. Researchers will analyze samples from 1,200 people with these conditions using advanced technology. The goal is to be…
Matched conditions: FTD
Sponsor: Ospedale Policlinico San Martino • Aim: Knowledge-focused
Last updated May 26, 2026 04:37 UTC